Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC

Improving Survival and Cure Rates in Resectable NSCLC With Perioperative ImmunotherapyПодробнее

Neoadjuvant, Adjuvant, or Both: Individualized Perioperative Immunotherapy in Resectable NSCLCПодробнее

IASLC Webinar: Perioperative Treatment w/Immune Checkpoint Inhibitors in Patients w/Resectable NSCLCПодробнее

Tailoring Your Perioperative Immunotherapy Approach for Resectable NSCLCПодробнее

Perioperative therapies in NSCLCПодробнее

Perioperative Immunotherapy for Resectable NSCLC: Evaluating Approved and Emerging ApproachesПодробнее

Are We Closer to a Cure With Perioperative Immunotherapy in Resectable NSCLC?Подробнее

Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLCПодробнее

How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans in Resectable NSCLCПодробнее

Early-Stage Resectable NSCLC: A Shifting Landscape With Targeted Therapies and ImmunotherapyПодробнее

AACR 2023 highlights on advances in the neoadjuvant treatment of resectable NSCLC with John HeymachПодробнее

Drs. Donington, Harpole, & Spicer discuss #NSCLC at #ITSOS2023 - https://bit.ly/NSCLC2023YПодробнее

Managing Early-Stage Resectable Non-Small Cell Lung Cancer: Through the Eyes of the Patient and t...Подробнее

Perioperative Nivolumab in Resectable NSCLC | NEJMПодробнее

"NEOTORCH Study: Perioperative Toripalimab + Chemotherapy vs. Chemotherapy in Resectable NSCLC |CRSFПодробнее

PERIOPERATIVE TREATMENT APPROACH IN RESECTABLE NSCLC Part 1: A surgeon’s perspectiveПодробнее

Integrating Perioperative Immunotherapy Strategies in NSCLCПодробнее

Dr. Cascone on Remaining Challenges With Perioperative Immunotherapy in NSCLCПодробнее

8 in 8 Series: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLCПодробнее